Last updated on November 2019

A Study to Assess the Efficacy Safety and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Brief description of study

Participants with diseases characterized by chronic pruritus experiencing moderate to severe pruritus will be enrolled in this pilot Phase 2 study.

The diseases characterized by chronic pruritus investigated in this pilot study currently include chronic idiopathic urticaria (CIU), chronic idiopathic pruritus (CIP), lichen planus (LP), lichen simplex chronicus (LSC) and plaque psoriasis (PPs).

Clinical Study Identifier: NCT03858634

Find a site near you

Start Over

Site 115

Johnston, RI United States
  Connect »